Weekly Dose #47: Remdesiver news; New opioid, SMA treatments; Sublingual epinephrine; Alzheimer treatment

<p><span style="font-weight: 400;">Remdesivir is submitted; New opioid approved by FDA; A new Spinal Muscular Atrophy treatment;  A sublingual epinephrine treatment; and the latest on Biogen’s investigational Alzheimer disease treatment.</span></p>